{
    "organizations": [],
    "uuid": "2e74cd5b4c07916c4277d83c42d16a920b2d4c0b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-navidea-biopharmaceuticals-says-on/brief-navidea-biopharmaceuticals-says-on-feb-17-co-entered-into-settlement-agreement-and-mutual-release-with-sinotau-idUSFWN1QD1C7",
    "ord_in_thread": 0,
    "title": "BRIEF-Navidea Biopharmaceuticals says ‍On Feb 17, co Entered Into Settlement Agreement And Mutual Release With Sinotau",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 23 (Reuters) - Navidea Biopharmaceuticals Inc:\n* NAVIDEA BIOPHARMACEUTICALS INC - ‍ON FEBRUARY 17, 2018, NAVIDEA ENTERED INTO A SETTLEMENT AGREEMENT AND MUTUAL RELEASE WITH SINOTAU - SEC FILING​\n* NAVIDEA BIOPHARMACEUTICALS - CO, SINOTAU AGREED TO STIPULATE TO VOLUNTARILY DISMISSAL OF ALL CLAIMS AGAINST EACH OTHER WITH PREJUDICE​ Source text - ( bit.ly/2osYMPY ) Further company coverage:\n ",
    "published": "2018-02-24T00:10:00.000+02:00",
    "crawled": "2018-02-24T13:38:51.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "navidea",
        "biopharmaceuticals",
        "inc",
        "navidea",
        "biopharmaceuticals",
        "inc",
        "february",
        "navidea",
        "entered",
        "settlement",
        "agreement",
        "mutual",
        "release",
        "sinotau",
        "sec",
        "navidea",
        "biopharmaceuticals",
        "co",
        "sinotau",
        "agreed",
        "stipulate",
        "voluntarily",
        "dismissal",
        "claim",
        "source",
        "text",
        "company",
        "coverage"
    ]
}